TIDES CMC Tracks - Event Guides

Oligonucleotide Chemistry, Manufacturing & Controls (CMC) Track

Dive into the cutting edge of oligonucleotide development with our dedicated CMC track, where scientific innovation meets practical application.

What You’ll Learn

Accelerate development through optimized CMC strategies that reduce risk and improve timelines
Master next-generation analytical techniques and QC to ensure product consistency and quality
Streamline regulatory pathways to bring therapies to market faster and more efficiently
Scale manufacturing with confidence, supported by real-world case studies and expert insights

Featured Keynote Sessions

“I Love Conjugates”: The GalNAc Revolution and Its Impact on Oligonucleotide Therapeutic Development

Muthiah (Mano) Manoharan PhD
Senior Vice President of Drug Innovation and Distinguished Research Scientist at Alnylam Pharmaceuticals

Tuesday, 20 May 2025
9:00am – 9:45am
Harbor Ballroom (Level 2)

Clinical Update on Oligonucleotides for Cardiovascular Disease

Sam Tsimikas, MD
Senior Vice President of Global Cardiovascular Development at Ionis Pharmaceuticals

Tuesday, 20 May 2025
1:00pm – 1:45pm
Harbor Ballroom (Level 2)

Whether you’re advancing toward commercialization or refining early-stage processes, this track delivers the tools and knowledge you need to drive oligo success from lab to launch. Make sure to check out our exciting sessions in these tracks.

#tidesusa